Portugal vs Singapore: Previously treated cases tested for RR-/MDR-TB
Portugal
49.0%
in 2024
Singapore
49.0%
in 2024
Portugal rank
151st
Singapore rank
151st
Previously treated cases tested for RR-/MDR-TB over time
- Portugal
- Singapore
How they compare
Portugal currently reports 49.0% against 49.0% in Singapore, a difference of 0.0%.
Across all 20 years both countries report, Singapore has been ahead every year.
Portugal ranks 151st and Singapore ranks 151st of 180 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Portugal | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.0% | 66.6% | 19.6% | Singapore |
| 2010s | 51.3% | 68.5% | 17.2% | Singapore |
| 2020s | 46.0% | 72.2% | 26.2% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Portugal or Singapore?
- Portugal, at 49.0% against 49.0% in Singapore as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Portugal and Singapore?
- 0.0%, with Portugal ahead.
- How many years of comparable data are there for Portugal and Singapore?
- 20 years are reported by both, from 2005 to 2024.
- How do Portugal and Singapore rank globally for previously treated cases tested for rr-/mdr-tb?
- Portugal ranks 151st and Singapore ranks 151st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.